GLP-1 RAs have demonstrated remarkable cardioprotective effects in patients with T2DM, consistently reducing the risks of nonfatal myocardial infarction, stroke, and cardiovascular death [196,197]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.